H Partners Obtains Clear Referendum for Change at Harley-Davidson’s 2025 Annual Meeting
Highlights that H Partners’ Campaign Compelled Harley’s Board to Make Commitments to Numerous Shareholders, Effectively Acquiescing to H Partners’ Demands... Read more.
Angel Oak Mortgage REIT, Inc. Announces Pricing of Public Offering of Senior Notes
ATLANTA–(BUSINESS WIRE)–Angel Oak Mortgage REIT, Inc. (NYSE: AOMR) (the “Company”) today announced that it has priced an underwritten public offering... Read more.
United Bankshares, Inc. Holds Annual Meeting of Shareholders
WASHINGTON & CHARLESTON, W.Va.–(BUSINESS WIRE)–United Bankshares, Inc. (“United”) (NASDAQ: UBSI), an approximately $33 billion regional financial... Read more.
The St. Joe Company Hosts 2025 Annual Meeting of Shareholders
PANAMA CITY BEACH, Fla.–(BUSINESS WIRE)–The St. Joe Company (NYSE: JOE) (“St. Joe”) (the “Company”) concluded its 2025 Annual Meeting of Shareholders... Read more.
Mayor Lurie, Intersect Power Announce New Headquarters in Historic Downtown San Francisco Building
Continues to Cement City as Global Hub of Growing AI and Clean Energy Industries; Marks Another Key Step for Downtown Recovery Under Mayor Lurie’s Leadership SAN... Read more.
Seacoast Receives Regulatory Approvals for the Acquisition of Heartland Bancshares, Inc.
STUART, Fla.–(BUSINESS WIRE)–Seacoast Banking Corporation of Florida (“Seacoast” or the “Company”) (NASDAQ: SBCF), the holding company for Seacoast... Read more.
Luminar Announces Leadership Transition
Paul Ricci Appointed CEO ORLANDO, Fla.–(BUSINESS WIRE)–Luminar Technologies, Inc. (Nasdaq: LAZR), a leading global automotive technology company, today... Read more.
FDA Approves Merck’s WELIREG® (belzutifan) for the Treatment of Adults and Pediatric Patients 12 Years and Older With Locally Advanced, Unresectable, or Metastatic Pheochromocytoma or Paraganglioma (PPGL)
WELIREG becomes the only approved and available treatment in the U.S. for eligible patients with advanced PPGL RAHWAY, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck... Read more.
GeoPark Provides Update on Transaction in Vaca Muerta, Argentina
BOGOTA, Colombia–(BUSINESS WIRE)–GeoPark Limited (“GeoPark” or the “Company”) (NYSE: GPRK), a leading independent energy company with over 20... Read more.
The New England Journal of Medicine Publishes Data from Phase 2b Trial of Oral Orexin Receptor 2 Agonist Oveporexton (TAK-861) in People with Narcolepsy Type 1
–Data Demonstrated Statistically Significant Improvements in Primary and Secondary Endpoints with Most Subjects Achieving Near Normal Ranges of Wakefulness and... Read more.